CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes-Reference-Cited by-同舟云学术

CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes

Published:2021-11 Issue:11 Volume:16 Page:2768-2783
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Olschok Kathrin,Han Lijuan,de Toledo Marcelo A.S.,Böhnke Janik,Graßhoff Martin,Costa Ivan G.,Theocharides Alexandre,Maurer Angela,Schüler Herdit M.,Buhl Eva Miriam,Pannen Kristina,Baumeister Julian,Kalmer Milena,Gupta Siddharth,Boor Peter,Gezer Deniz,Brümmendorf Tim H.,Zenke Martin,Chatain Nicolas,Koschmieder Steffen^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference50 articles.

1. Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis;Abbonante;Stem Cells,2016

2. Using CRISPR/cas9 gene editing to investigate the oncogenic activity of mutant calreticulin in cytokine dependent hematopoietic cells;Abdelfattah;J. Vis. Exp.,2018

3. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms;Araki;Blood,2016

4. Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation;Araki;Leukemia,2019

5. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion;Barbui;Blood Cancer J.,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche;Stem Cell Reports;2024-02

2. Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms;Cell Reports;2024-01

3. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings;BMC Urology;2023-12-04

4. The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling;Frontiers in Oncology;2023-10-24

5. Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies;Advances in Biological Regulation;2023-09